These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18997213)

  • 1. Diffusion of new technology and payment policies: coronary stents.
    Shih C; Berliner E
    Health Aff (Millwood); 2008; 27(6):1566-76. PubMed ID: 18997213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Policy implications of the diffusion and control of medical technology.
    Banta HD; Burns AK; Behney CJ
    Ann Am Acad Pol Soc Sci; 1983 Jul; (468):165-81. PubMed ID: 10299096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diffusion of medical technology, local conditions, and technology re-invention: a comparative case study on coronary stenting.
    Hashimoto H; Noguchi H; Heidenreich P; Saynina O; Moreland A; Miyazaki S; Ikeda S; Kaneko Y; Ikegami N
    Health Policy; 2006 Dec; 79(2-3):221-30. PubMed ID: 16473435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion of medical technology: the role of financing.
    Cappellaro G; Ghislandi S; Anessi-Pessina E
    Health Policy; 2011 Apr; 100(1):51-9. PubMed ID: 21055840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program.
    Ryan J; Linde-Zwirble W; Engelhart L; Cooper L; Cohen DJ
    Circulation; 2009 Feb; 119(7):952-61. PubMed ID: 19204307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 3: payment.
    Raab GG; Parr DH
    J Am Coll Radiol; 2006 Nov; 3(11):842-50. PubMed ID: 17412183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim funding suggested for specific kinds of new technologies prior to DRG adjustments.
    Mannen T; Campbell P
    Rev Fed Am Hosp; 1985; 18(4):44-7. PubMed ID: 10300252
    [No Abstract]   [Full Text] [Related]  

  • 8. Implementing evidence-based medicine through medicare coverage decisions.
    Foote SB; Town RJ
    Health Aff (Millwood); 2007; 26(6):1634-42. PubMed ID: 17978383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services.
    Smith JJ; Henderson JA
    J Am Coll Radiol; 2008 Mar; 5(3):189-92. PubMed ID: 18312966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Payment policy and the growth of Medicare Advantage.
    Zarabozo C; Harrison S
    Health Aff (Millwood); 2009; 28(1):w55-67. PubMed ID: 19029153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with Medicare's new technology add-on payment program.
    Clyde AT; Bockstedt L; Farkas JA; Jackson C
    Health Aff (Millwood); 2008; 27(6):1632-41. PubMed ID: 18997222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare as incubator for innovation in payment policy.
    Janus K; Brown LD
    J Health Polit Policy Law; 2007 Apr; 32(2):293-306. PubMed ID: 17463408
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffusion of new technologies: rational and irrational.
    Perry S
    J Health Care Technol; 1984; 1(2):73-88. PubMed ID: 10271139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on the reimbursement paradox.
    Reaven NL; Rosenbloom J
    Crit Care Med; 2009 Jul; 37(7 Suppl):S285-9. PubMed ID: 19535960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Don't let cost containment stifle technological innovation.
    Bessey EC
    Med Mark Media; 1986 Jan; 21(1):8-10, 14, 16. PubMed ID: 10275185
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffusion of new technologies. Can Medicare payment decisions be made faster and more efficiently?
    VanAntwerp M
    J Health Care Technol; 1985; 2(2):97-103. PubMed ID: 10300492
    [No Abstract]   [Full Text] [Related]  

  • 17. A happy new year for ASCs?
    Zimmerman E
    Healthc Financ Manage; 2007 Dec; 61(12):64-9. PubMed ID: 18186205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for greater price transparency in the medical device industry: an economic analysis.
    Hahn RW; Klovers KB; Singer HJ
    Health Aff (Millwood); 2008; 27(6):1554-9. PubMed ID: 18997211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Just ask: a proposal to hone the indications for sophisticated radiology examinations.
    Bernstein J; Lexa FJ
    J Med Pract Manage; 2010; 25(6):360-3. PubMed ID: 20695248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruptive technology: new medical advances are troublesome for even the most successful health systems and innovator health companies.
    Michaelis L; Vaul J; Chumer K; Faul M; Sheehan L; DeCerce J
    J Cardiovasc Manag; 2004; 15(2):9-12. PubMed ID: 15185624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.